Vext Science Inc
CNSX:VEXT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Vext Science Inc
Operating Income
Vext Science Inc
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
V
|
Vext Science Inc
CNSX:VEXT
|
Operating Income
-$3.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Operating Income
$2.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
11%
|
CAGR 10-Years
0%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Operating Income
-CA$52.8m
|
CAGR 3-Years
57%
|
CAGR 5-Years
42%
|
CAGR 10-Years
-9%
|
|
|
Cronos Group Inc
TSX:CRON
|
Operating Income
-$14.6m
|
CAGR 3-Years
48%
|
CAGR 5-Years
39%
|
CAGR 10-Years
-23%
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Operating Income
-$151.2m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-57%
|
CAGR 10-Years
-123%
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Operating Income
CA$5.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vext Science Inc
Glance View
Vext Science, Inc. engages in the cultivation, extraction, and wholesale distribution of cannabis products. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-05-13. The firm utilizes a vertical integration business model to execute all aspects of cultivation, extraction, manufacturing (tetrahydrocannabinol (THC) and cannabidiol (CBD) cartridges, concentrates, edibles), retail dispensary, and wholesale distribution of cannabis THC and hemp CBD products. The company provides these management and marketing services in Arizona to two licensed dispensaries. The firm has developed a standard operating procedures (SOPs) to produce a full line of branded flower, Vapen branded THC and CBD distillates, concentrates, extracts, and edibles. The company operates a service business for cannabis cultivation and processing located in the State of Arizona. The firm's products produced under contract are sold through Herbal Wellness Center and Organica Patient Group Medical Marijuana Dispensary, both licensed not-for-profit dispensaries located in Phoenix, Arizona.
See Also
What is Vext Science Inc's Operating Income?
Operating Income
-3.5m
USD
Based on the financial report for Sep 30, 2025, Vext Science Inc's Operating Income amounts to -3.5m USD.
What is Vext Science Inc's Operating Income growth rate?
Operating Income CAGR 1Y
74%
Over the last year, the Operating Income growth was 74%.